<DOC>
	<DOC>NCT01529775</DOC>
	<brief_summary>This study will demonstrate the benefits of platform switching design of the Osseotite dental implant.</brief_summary>
	<brief_title>Randomized Study of Osseotite Certain Tapered Prevails vs. Osseotite Certain Tapered</brief_title>
	<detailed_description>The Osseotite Certain Prevail implant with its platform switch feature will demonstrate higher success rate than the non-platform Osseotite Certain implant</detailed_description>
	<mesh_term>Tooth Diseases</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Povidone-Iodine</mesh_term>
	<criteria>patients of either sex and older than 18 years of age patients needing at least one dental implant to treat partial edentulism patients physically able to tolerate surgical and restorative dental procedures patients agreeing to all protocol visits patients with infection or severe inflammation at the intended treatment sites patients smoking greater than 10 cigarettes per day patients with uncontrolled diabetes mellitus patients with uncontrolled metabolic diseases patients who received radiation treatment to the head in the past 12 months patients needing bone grafting at the intended treatment sites patients known to be pregnant at screening visit patients with parafunctional habits like bruxing and clenching</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>partial edentulism</keyword>
	<keyword>dental implants</keyword>
	<keyword>Osseotite Certain Prevail Tapered</keyword>
	<keyword>Osseotite Certain Tapered</keyword>
	<keyword>Crestal bone level</keyword>
	<keyword>randomized</keyword>
	<keyword>clinical study</keyword>
</DOC>